Home Sectors Healthcare Stock in the Spotlight: Express Scripts Holding Company (NASDAQ: ESRX)

Stock in the Spotlight: Express Scripts Holding Company (NASDAQ: ESRX)


Express Scripts Holding Company trades as part of the health care plans industry and is in the healthcare sector. The company CEO is Timothy C. Wentworth. Express Scripts Holding Co is a pharmacy benefit manager in the United States. It offers healthcare management and administration services such as managed care organizations, health insurers, workers’ compensation plans and government health programs.

Previous Intraday Trading Performance:

The ESRX stock showed a previous change of 0.00% with an open at 95.57 and a close of 92.33. It reached an intraday high of 95.87 and a low of 92.11.

SeekingAlpha:  Keeping Focused Amidst The Biotech Bear


The stock has a market cap of $52.1b with 563.9m shares outstanding, of which the float is 560.2m shares. Trading volume reached 30,012,725 shares compared to its average volume of 6,013,217 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Express Scripts Holding Company shares returned -6.00% and in the past 30 trading days it returned -7.19%. Over three months, it changed -2.19%. In one year it has changed 23.12% and within that year its 52-week high was 101.73 and its 52-week low was 66.93. ESRX stock is 37.95% above its 52 Week Low.

Our calculations show a 200 day moving average of 84.26 and a 50 day moving average of 96.70. Currently ESRX stock is trading 9.57% above its 200 day moving average.

SeekingAlpha:  Keeping Focused Amidst The Biotech Bear


The last annual fiscal EPS for the company was reported at 7.75 that ended on 31st of December 2017, which according to the previous close, that is a PE of 11.91. Based on 11 analyst estimates, the consensus EPS for the next quarter is 2.42. The TTM EPS is 8.58, which comes to a TTM PE of 10.76. Historically, the PE high was 38.70 and the PE low was 10.40. If the stock reached its PE low, that would represent a price of 89.24, which is a decrease of -3.35%.

The following are the last four quarter reported earnings per share:
09-30-2018:  2.43
06-30-2018:  2.22
03-31-2018:  1.77
12-31-2017:  2.16

Base on our calculations, the intrinsic value per share is 104.01, which means it is possibly undervalued and has a margin of safety of 11.23%

Indicators to Watch:

Based on the latest filings, there is 0.70% of insider ownership and 122.80% of institutional ownership. Short-interest is 0, which is 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio is 0.00.

The current calculated beta is 0.84

CNBC:  Stocks making the biggest moves premarket: Hasbro, Coty, Expedia, Verizon & more

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 26.86%, return on assets is 9.19%, profit margin is 5.00%, price-to-sales is 0.53 and price-to-book is 2.53.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 6  :Past Performance Score
 2  :Financial Strength Score
 0  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.